Drug class
Long-chain saturated fatty alcohol; topical antiviral entry inhibitor
Mechanism of action
Interferes with fusion between the viral envelope and host-cell plasma membrane, preventing entry of herpes simplex virus into cells. It does not inactivate established intracellular viral replication.
General use cases
- Topical treatment of recurrent herpes labialis (cold sores) in adults and adolescents aged 12 years and older, with initiation at the earliest prodromal symptom under the US product indication
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
